We are live on ! Find out more

Traws Pharma

TRAW

Market cap $8.26M

8 hedge funds and large institutions have $2.5M invested in Traws Pharma in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New

Increased

Maintained

Reduced

Closed

11% less funds holding

Funds holding: 9 → 8 (-1)

11% less capital invested

Capital invested by funds: $2.81M → $2.5M (-$314K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $34K

Holders

Holders Change

-1

Holders Change %

-11.11%

% of All Funds

0.22%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

–

Reduced

–

Closed

Calls

–

Puts

$34K

Net Calls

-$34K

Net Calls Change

-$26K

Top Buyers

Rank	Fund	Capital Flow
1	Jacobs Levy Equity Management Florham Park, New Jersey	+$143K

Top Sellers

Rank	Fund	Capital Flow
1	Alyeska Investment Group Chicago, Illinois	-$221K
2	Goldman Sachs New York	-$143K
3	D.E. Shaw & Co New York	-$64K
4	SIM Spark Investment Management New York	-$34K
5	Janney Montgomery Scott Philadelphia, Pennsylvania	-$28K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Vanguard Group Malvern, Pennsylvania	$690K	–	–	–
2	WMSA 2 Weiss Multi-Strategy Advisers New York	$571K	–	–	–
3	3 Citigroup New York	$324K	–	–	–
4	4 Renaissance Technologies New York	$212K	–	–	–
5	5 Jacobs Levy Equity Management Florham Park, New Jersey	$139K	+$143K	+1	New
6	6 Royal Bank of Canada Toronto, Ontario, Canada	$118K	–	–	–
7	7 Geode Capital Management Boston, Massachusetts	$108K	–	–	–
8	BFA 8 BlackRock Fund Advisors San Francisco, California	$82K	–	–	–
9	9 Goldman Sachs New York	$61K	-$143K	-1	Closed
10	HK 10 Horizon Kinetics New York	$50K	–	–	–
11	11 HighTower Advisors Chicago, Illinois	$43K	–	–	–
12	BCM 12 Bridgeway Capital Management Houston, Texas	$28K	–	–	–
13	13 Northern Trust Chicago, Illinois	$27K	–	–	–
14	14 Bank of America Charlotte, North Carolina	$17K	–	–	–
15	BIM 15 BlackRock Investment Management Wilmington, Delaware	$5K	–	–	–
16	16 Group One Trading Chicago, Illinois	$5K	–	–	–
17	17 Deutsche Bank Frankfurt Am Main Ge, Germany	$4K	–	–	–
18	18 Morgan Stanley New York	$4K	–	–	–
19	19 UBS Group Zurich, Switzerland	$3K	–	–	–
20	TRCT 20 Tower Research Capital (TRC) New York	$2K	–	–	–
21	DA 21 Dunvegan Associates Santa Barbara, California	$1K	–	–	–
22	NFG 22 Next Financial Group Houston, Texas	$1K	–	–	–
23	23 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$2	–	–	–
24	24 Alyeska Investment Group Chicago, Illinois	–	-$221K	-2	Closed
25	25 D.E. Shaw & Co New York	–	-$64K	–	–

TRAW Hedge Fund Activity: Q2 2015 in Review

8 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q2 2015, worth a combined $2.5M — down 11% from $2.81M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TRAW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $143K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $221K sold.

8 institutional investors held Traws Pharma (TRAW) as of Q2 2015, down from 9 in Q1 2015.
Funds reported $2.5M of Traws Pharma stock for Q2 2015, down 11% quarter-over-quarter.
1 fund opened new Traws Pharma positions in Q2 2015 and 2 closed out, a net change of -1 holder.
The largest Traws Pharma buyer in Q2 2015 was Jacobs Levy Equity Management, an estimated $143K added.
The largest Traws Pharma seller in Q2 2015 was Alyeska Investment Group, an estimated $221K sold.

Based on aggregated 13F filings for Q2 2015.

Traws Pharma TRAW Market cap $8.26M